|
"chung h c"的相關文件
顯示項目 46-70 / 82 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-05-25T07:35:17Z |
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results from the phase Ib KEYNOTE-012 expansion cohort
|
Seiwert T.Y.; Cheng J.D; Pathiraja K; Dolled-Filhart M; Meister A; Chung H.C; Chow L.Q.M; Haddad R; Gupta S; Mahipal A; Mehra R; Tahara M; Berger R; Eder J.P; Burtness B; Lee S.-H; Keam B; Kang H; Muro K; Weiss J; Geva R; Chia-Chi Lin |
| 臺大學術典藏 |
2020-05-25T07:35:12Z |
Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012
|
Tahara M; Muro K; Hasegawa Y; Chung H.C; Chia-Chi Lin; Keam B; Takahashi K; Cheng J.D; Bang Y.-J. |
| 臺大學術典藏 |
2020-05-25T07:35:10Z |
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012
|
Cheng J; Chow L.Q.M; Haddad R.; Pathiraja K; Aurora-Garg D; Ray A; Chia-Chi Lin; Chung H.C; Geva R; Mehra R; Seiwert T.Y; Gupta S; Weiss J; Gluck I; Eder J.P; Burtness B; Tahara M; Keam B; Kang H; Muro K |
| 臺大學術典藏 |
2020-05-25T07:35:08Z |
Phase I study results from an esophageal squamous cell carcinoma (ESCC) cohort treated with M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor �] (TGF-�]) and PD-L1
|
Chia-Chi Lin; Doi T; Muro K; Hou M.-M; Esaki T; Hara H; Chung H.-C; Osada M; Helwig C; Kondo S. |
| 臺大學術典藏 |
2020-03-27T05:30:26Z |
Clinical experience of 17 cases of imported malaria at a Taiwan university hospital, 1999-2005
|
Chang S.-C.;Chen Y.-C.;PO-REN HSUEH;Fang C.-T.;Hsieh S.-M.;Sheng W.-H.;Lo Y.-C.;Wang J.-L.;Sun H.-Y.;Wang J.-T.;Chung H.-C.; Chung H.-C.; Wang J.-T.; Sun H.-Y.; Wang J.-L.; Lo Y.-C.; Sheng W.-H.; Hsieh S.-M.; Fang C.-T.; PO-REN HSUEH; Chen Y.-C.; Chang S.-C. |
| 國立成功大學 |
2020 |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen, L.-T.;Satoh, T.;Ryu, M.-H.;Chao, Y.;Kato, Kato K.;Chung, H.C.;Chen, J.-S.;Muro, K.;Kang, W.K.;Yeh, K.-H.;Yoshikawa, T.;Oh, S.C.;Bai, L.-Y.;Tamura, Tamura T.;Lee, K.-W.;Hamamoto, Y.;Kim, J.G.;Chin, K.;Oh, D.-Y.;Minashi, K.;Cho, J.Y.;Tsuda, M.;Sameshima, H.;Kang, Y.-K.;Boku, N. |
| 國立成功大學 |
2020 |
Athermal Silicon Power Splitter using Shortcuts to Adiabaticity
|
Chung, H.-C.;Wang, T.-C.;Lu, G.-X.;Wu, C.-H.;Hung, Y.-J.;Tseng, S.-Y. |
| 國立成功大學 |
2019 |
Safety and efficacy of nivolumab in combination with s-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (a
|
Boku, N.;Ryu, M.-H.;Kato, Kato K.;Chung, H.C.;Minashi, K.;Lee, K.-W.;Cho, H.;Kang, W.K.;Komatsu, Y.;Tsuda, M.;Yamaguchi, K.;Hara, Hara H.;Fumita, S.;Azuma, M.;Chen, L.-T.;Kang, Y.-K. |
| 國立成功大學 |
2019 |
Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial
|
Yoshikawa, T.;Muro, K.;Shitara, K.;Oh, D.-Y.;Kang, Y.-K.;Chung, H.C.;Kudo, T.;Chin, K.;Kadowaki, S.;Hamamoto, Y.;Hironaka, S.;Yoshida, K.;Yen, C.-J.;Omuro, Y.;Bai, L.-Y.;Maeda, K.;Ozeki, A.;Yoshikawa, R.;Kitagawa, Y. |
| 國立成功大學 |
2019 |
Spin-polarized magneto-electronic properties in buckled monolayer GaAs
|
Chung, H.-C.;Chiu, Chiu C.-W.;Lin, M.-F. |
| 國立成功大學 |
2019 |
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
|
Moehler, Moehler M.;Ryu, M.-H.;Dvorkin, M.;Lee, K.-W.;Coşkun, H.Ş.;Wong, R.;Chung, H.C.;Poltoratsky, A.;Tsuji, A.;Yen, C.J.;Muntean, A.S.;Le, Sourd S.;Vaccaro, G.M.;Overton, L.;Boku, N.;Wainberg, Z.A.;Patel, M.;Sharma, M.;Xiong, H.;Conti, I.;Taieb, J.;Bang, Y.-J. |
| 國立成功大學 |
2019 |
Robust couplers designed by fast quasiadiabatic elimination
|
Chung, H.-C.;Sie, J.-Y.;Tseng, S.-Y. |
| 國立成功大學 |
2019 |
The fast quasiadiabatic approach to optical waveguide design
|
Chung, H.-C.;Li, Z.-Y.;Liang, F.-C.;Lee, K.-S.;Tseng, S.-Y. |
| 臺大學術典藏 |
2018-09-10T05:14:40Z |
Evaluation of the low cost telemedicine system in Taiwan
|
Luh, J.J.; Cheng, P.H.; Chen, S.J.; Lai, J.S.; Chen, H.S.; Chung, H.C.; JER-JUNN LUH; JIN-SHIN LAI; SAO-JIE CHEN |
| 亞洲大學 |
2018-01 |
Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.
|
Chung, H.C.;Chung, H.C.;郭集慶;Kok, Victor C.;Chen, Rebecca;Cheng, Rebecca;Hsu, Y.;Hsu, Y.;Orlando, M.;Orlando, M.;Fuchs, C.;Fuchs, C.;Cho, J.Y.;Cho, J.Y.;* |
| 國立成功大學 |
2018 |
Atomistic full-quantum transport model for zigzag graphene nanoribbon-based structures: Complex energy-band method
|
Chen, Chen C.-N.;Luo, W.-J.;Shyu, F.-L.;Chung, H.-C.;Lin, C.-Y.;Wu, J.-Y. |
| 國立成功大學 |
2018 |
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
|
Yen, C.-J.;Muro, K.;Kim, T.-W.;Kudo, M.;Shih, J.-Y.;Lee, K.-W.;Chao, Y.;Kim, S.-W.;Yamazaki, K.;Sohn, J.;Cheng, R.;Zhang, Y.;Binder, P.;Mi, G.;Orlando, M.;Chung, H.C. |
| 國立成功大學 |
2018 |
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study
|
Chau, I.;Park, J.O.;Ryoo, B.-Y.;Yen, C.-J.;Poon, R.;Pastorelli, D.;Blanc, J.-F.;Kudo, M.;Pfiffer, T.;Hatano, E.;Chung, H.C.;Kopeckova, Kopeckova K.;Phelip, J.-M.;Brandi, G.;Ohkawa, S.;Li, C.-P.;Okusaka, T.;Hsu, Y.;Abada, P.B.;Zhu, A.X. |
| 國立成功大學 |
2017 |
Robust silicon 3-dB coupler using inverse engineering based optimization
|
Chung, H.-C.;Tseng, S.-Y. |
| 國立成功大學 |
2017 |
Efficient silicon-on-insulator taper using fast quasiadiabatic dynamics
|
Chung, H.-C.;Tseng, S.-Y. |
| 國立臺灣科技大學 |
2016 |
Flow characteristics and drag force of a square cylinder in crossflow modulated by a slot jet injected from upstream surface
|
Hsu, C.M;Huang, R.F;Chung, H.C. |
| 國立成功大學 |
2015-09 |
Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment
|
Chau, I.; Park, J. O.; Ryoo, B. Y.; Yen, C. J.; Poon, R.; Pastorelli, D.; Blanc, J. F.; Kudo, M.; Pfiffer, T. F.; Hatano, E.; Chung, H. C.; Kubackova, K.; Phelip, J. M.; Brandi, G.; Ohkawa, S.; Li, C. P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. |
| 國立成功大學 |
2015-08-23 |
Electronic and optical properties in graphane
|
Lee, M. H.; Chung, H. C.; Lu, J. M.; Chang, C. P.; Lin, M. F. |
| 國立成功大學 |
2014 |
Destruction of Landau levels in asymmetric bilayer nanographene ribbons
|
Lee, M. H.; Chung, H. C.; Lin, C. Y.; Lin, M. F. |
| 淡江大學 |
2013-05 |
Vision-based localization system for XY tracking platform
|
Cheng, C.T.; Wong, C.C.; Chung, H. C.; Hu, Y.Y.; Liou, D.J.; Wu, J.H. |
顯示項目 46-70 / 82 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
